8月10日，Tempus AI盘中上涨5.1%，报54.67美元/股，成交额4124.98万美元。
消息面上，公司此前发布的Q2财报表现大幅超预期：调整后每股亏损0.04美元，远优于市场预期的亏损0.14美元，同比收窄81.82%；营收3.825亿美元，同比增长21.6%，超出市场预期的3.797亿美元。同时公司上调全年营收指引至16.0亿至16.1亿美元，高于市场预期的15.9亿美元。此外，公司以约15亿美元企业价值收购癌症检测公司Personalis的战略布局，将分子残留病灶检测整合至AI精准肿瘤学平台，进一步拓展业务版图，市场对公司盈利修复与并购整合前景持续看好。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.